immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.
http://www.immatics.asia/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
immatics biotechnologies
Emmerich Niels
Paul-Eh●●●●●●●Str. 15
Tue●●●gen , Germany, 72076
DE
View this contact
Emmerich Niels
Paul-Eh●●●●●●●Str. 15
Tue●●●gen , Germany, 72076
DE
View this contact
Cronon AG IT-Services
Strato Rechenzentrum Hostmaster
Emmy-No●●●●●●●Str. 10
Kar●●●uhe , Germany, D-76131
DE
View this contact
iTECS Communications Pvt. Ltd.
Kurian Devasia
16th B ●●●●●●●o. 2450
HAL II S●●●●●●●●iranagar
Ban●●●ore , Karnataka, 560008
IN
View this contact
BUY YOUR DOMAIN
ASIA Registry R6-ASIA (700001) Cronon AG Berlin Niederlassung Regensburg R153-ASIA (141)
WHOIS : asia.whois-servers.net
REFERRED :
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
0
SITE IP
81.169.145.156
LOAD TIME
0 sec
SCORE
6.2
immatics biotechnologies - active against cancer | immatics.asia Reviews
https://immatics.asia
immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.
immatics.asia
Home | Immatics
http://www.immatics.asia/index.php?page=91&modid2=2013&PHPSESSID=3a10ecec866ac48efb3a2037d1e1c90d
Immatics US, Inc. Adoptive Cellular Therapy (ACT). Adoptive Cellular Therapy (ACT). Careers – GmbH. Careers – U.S. Contact – GmbH. Contact – U.S. Immatics is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Immatics is a leading cancer immunotherapy company and. Global leader in the discovery of novel targets for various types of cancer immunotherapies. In designing our immunotherapies we employ a unique and rational approach base...
TOTAL PAGES IN THIS WEBSITE
1
Welcome to www.immatesearch.com - Search Results for "immatesearch.com"
Click here to proceed.
ImmAtheOwN - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 7 Years. This deviant's full pageview. Last Visit: 252 weeks ago. This is the place where you can personalize your profile! 1048;&#...
imma.being | Pain & Performance Solutions
Pain and Performance Solutions. Transform & Transcend. 100% Guarantee of a Healing Experience – To Be Listened To and To Upgrade Function. Dedicated to helping you upgrade through an evidence-based practice, drawing from ancient wisdom, to elevate human potential, consciousness, and health. In all sessions Michael facilitates change and your personal evolution using education, touch, movement and acupuncture therapy, providing you the power to fully express your mind, body, and spirit in this life. Culti...
Blog de immathias - Immathias vous présente : ^^ les MARSEILLER ^^ - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Immathias vous présente : les MARSEILLER. Voilla comme promis je reparle de marseille. Mise à jour :. L'Olympique de Marseille s. Ecoute Skyrock en live. Les n 1 sont Rap and RnB. Abonne-toi à mon blog! L'Olympique de Marseille souhaite à tous ses supporters une belle et heureuse année 2010! Que lit-on sur la page qui se tourne? Est-il utile de préciser que rien n'est perdu? Inscrire une nouvelle ligne au palmarès en 2010? Ce serait la délicieuse cerise sur l...
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
Home - Immatics
Bringing the Power of T cells to Cancer Patients. Proprietary and Partnered Immune-oncology Programs. World Class Team and Science. Go to Bispecific TCR Molecules. Immatics has developed three innovative approaches to producing Adoptive Cell Therapies (ACT): ACTolog. These therapies are directed against targets which will transform the current landscape of tumor therapy. Bispecific T-Cell Receptor Molecules. About Bispecific T-Cell receptor molecules. MorphoSys and Immatics Biotechnologies Enter Strategi...
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
Home - Immatics
Bringing the Power of T cells to Cancer Patients. Proprietary and Partnered Immune-oncology Programs. World Class Team and Science. Go to Bispecific TCR Molecules. Immatics has developed three innovative approaches to producing Adoptive Cell Therapies (ACT): ACTolog. These therapies are directed against targets which will transform the current landscape of tumor therapy. Bispecific T-Cell Receptor Molecules. About Bispecific T-Cell receptor molecules. MorphoSys and Immatics Biotechnologies Enter Strategi...
SOCIAL ENGAGEMENT